Wendy Comisar

A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients with Advanced Cancer

Jaclyn K Patterson, P. Munster, J. Wagner, 2009, Clinical Cancer Research.

A semimechanistic model of the time‐course of release of PTH into plasma following administration of the calcilytic JTT‐305/MK‐5442 in humans

D. S. Ross, Khamir Mehta, Rajiv P. Shrestha, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants

P. Deutsch, J. Wagner, J. Stone, 2011, Journal of clinical pharmacology.

Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals

R. Bertz, A. Persson, J. Butterton, 2010, Antiviral therapy.

Caspofungin exposure‐response relationships in adult patients with mucosal or invasive candidiasis

J. Chow, N. Kartsonis, C. Sable, 2014, Clinical pharmacology in drug development.

A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients with Advanced Cancer

P. Munster, J. Wagner, E. Rubin, 2009, Clinical Cancer Research.